Despite the modest sample size (n = 603), the results of the GWAS meta-analysis suggest that variants in PARK2 may be associated with the development of PTSD, which is in agreement with the largest PTSD-GWAS meta-analysis conducted to date (Nievergelt et al., 2019). This evidence concerns the gene PRKN and post-traumatic stress disorder.